Patents by Inventor Robert S. Becker
Robert S. Becker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10057270Abstract: A computer system supports hosting of virtual desktops using resources available in the cloud. Connections to various resources used by a desktop configuration are made dynamically using authentication information associated with the user assigned to the desktop configuration. In addition to using file storage, directory services and user management information on private resources on a private network, these resources may also be accessed through a public network.Type: GrantFiled: November 30, 2015Date of Patent: August 21, 2018Assignee: VMware, Inc.Inventors: Kenneth N. Ringdahl, Steven J. Baron, Pranay Ahlawat, Robert S. Becker, Peter C. McKay
-
Publication number: 20160193329Abstract: Compositions that include at least a portion of a flagellin and an antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to infection.Type: ApplicationFiled: November 4, 2015Publication date: July 7, 2016Inventors: Langzhou Song, Lynda G. Tussey, Alan R. Shaw, Robert S. Becker, Yi Zhang, Scott W. Umlauf, Ge Liu
-
Publication number: 20160087992Abstract: A computer system supports hosting of virtual desktops using resources available in the cloud. Connections to various resources used by a desktop configuration are made dynamically using authentication information associated with the user assigned to the desktop configuration. In addition to using file storage, directory services and user management information on private resources on a private network, these resources may also be accessed through a public network.Type: ApplicationFiled: November 30, 2015Publication date: March 24, 2016Applicant: VMware, Inc.Inventors: Kenneth N. Ringdahl, Steven J. Baron, Pranay Ahlawat, Robert S. Becker, Peter C. McKay
-
Patent number: 9211320Abstract: Compositions that include at least a portion of a flagellin and an antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to infection.Type: GrantFiled: December 17, 2014Date of Patent: December 15, 2015Assignee: VaxInnate CorporationInventors: Langzhou Song, Lynda G. Tussey, Alan R. Shaw, Robert S. Becker, Yi Zhang, Scott W. Umlauf, Ge Liu
-
Patent number: 9205138Abstract: Compositions that include Toll-like Receptor 5 agonists and at least a portion of at least one viral antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to viral infection.Type: GrantFiled: December 16, 2014Date of Patent: December 8, 2015Assignee: VaxInnate CorporationInventors: Langzhou Song, Lynda G. Tussey, Alan R. Shaw, Robert S. Becker, Yi Zhang, Scott W. Umlauf, Ge Liu
-
Patent number: 9201667Abstract: A computer system supports hosting of virtual desktops using resources available in the cloud. Connections to various resources used by a desktop configuration are made dynamically using authentication information associated with the user assigned to the desktop configuration. In addition to using file storage, directory services and user management information on private resources on a private network, these resources may also be accessed through a public network.Type: GrantFiled: December 30, 2011Date of Patent: December 1, 2015Assignee: VMware, Inc.Inventors: Kenneth Ringdahl, Steven Baron, Pranay Ahlawat, Robert S. Becker, Peter C. McKay
-
Publication number: 20150110832Abstract: Compositions that include Toll-like Receptor 5 agonists and at least a portion of at least one viral antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to viral infection.Type: ApplicationFiled: December 16, 2014Publication date: April 23, 2015Inventors: Langzhou Song, Lynda G. Tussey, Alan R. Shaw, Robert S. Becker, Yi Zhang, Scott W. Umlauf, Ge Liu
-
Publication number: 20150099859Abstract: Compositions that include at least a portion of a flagellin and an antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to infection.Type: ApplicationFiled: December 17, 2014Publication date: April 9, 2015Inventors: Langzhou Song, Lynda G. Tussey, Alan R. Shaw, Robert S. Becker, Yi Zhang, Scott W. Umlauf, Ge Liu
-
Patent number: 8932605Abstract: Compositions that include Toll-like Receptor 5 agonists and at least a portion of at least one viral antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to viral infection.Type: GrantFiled: October 15, 2010Date of Patent: January 13, 2015Assignee: VaxInnate CorporationInventors: Langzhou Song, Lynda G. Tussey, Alan R. Shaw, Robert S. Becker, Yi Zhang, Scott W. Umlauf, Ge Liu
-
Publication number: 20120179820Abstract: A computer system supports hosting of virtual desktops using resources available in the cloud. Connections to various resources used by a desktop configuration are made dynamically using authentication information associated with the user assigned to the desktop configuration. In addition to using file storage, directory services and user management information on private resources on a private network, these resources may also be accessed through a public network.Type: ApplicationFiled: December 30, 2011Publication date: July 12, 2012Applicant: DESKTONE, INC.Inventors: Kenneth Ringdahl, Steven Baron, Pranay Ahlawat, Robert S. Becker, Peter C. McKay
-
Publication number: 20110135680Abstract: Compositions that include Toll-like Receptor 5 agonists and at least a portion of at least one viral antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to viral infection.Type: ApplicationFiled: October 15, 2010Publication date: June 9, 2011Inventors: Langzhou Song, Lynda G. Tussey, Alan R. Shaw, Robert S. Becker, Yi Zhang, Scott W. Umlauf, David N. Taylor, Ge Liu, Mark D. Yeager
-
Patent number: 7235243Abstract: Immununological compositions and methods for making and using them. The compositions contain at least one antigen and at least one lipoprotein and optionally an adjuvant. The lipoprotein can itself be antigenic or immunogenic. The antigen can be influenza HA and the lipoprotein a recombinantly expressed product having an OspA leader for lipidation and PspA for the protein portion. The antigen can be OspC and the lipoprotein OspA. The components of the composition are co-administered. A potentiated immunological response is obtained by the compositions and methods.Type: GrantFiled: July 1, 2005Date of Patent: June 26, 2007Assignee: Connaught Laboratories, Inc.Inventors: Robert S. Becker, Robert C. Huebner, Maryann Gray, Karen S. Biscardi, Lorne F. Erdile, Bruno Guy
-
Patent number: 7189404Abstract: The present invention relates to vaccine composition(s) comprising at least two PspAs from strains selected from at least one family, the family being defined by PspAs from strains belonging to the family having greater than or equal to 50% homology in aligned sequences of a C-terminal region of an alpha helical region of PspA. Additionally, the families are further comprised of clades, wherein PspAs from strains which belong to a clade exhibit greater than 75% sequence homology in aligned sequences of the C-terminal region of the alpha helix of PspA. Vaccine compositions of the present invention preferably comprise a minimum of 4 and a maximum of 6 strains representing a single clade each, and the at least two PspAs are optionally serologically or broadly cross-reactive.Type: GrantFiled: September 30, 2003Date of Patent: March 13, 2007Assignee: The UAB Research FoundationInventors: Robert S. Becker, David E. Briles, Susan Hollingshead
-
Patent number: 6984385Abstract: Immunological compositions and methods for making and using them. The compositions contain at least one antigen and at least one lipoprotein and optionally an adjuvant. The lipoprotein can itself be antigenic or immunogenic. The antigen can be influenza HA and the lipoprotein a recombinantly expressed product having an OspA leader for lipidation and PspA for the protein portion. The antigen can be OspC and the lipoprotein OspA. The components of the composition are co-administered. A potentiated immunological response is obtained by the compositions and methods.Type: GrantFiled: March 12, 2002Date of Patent: January 10, 2006Assignee: Connaught Laboratories, Inc.Inventors: Robert S. Becker, Robert C. Huebner, Maryann Gray, Karen S. Biscardi, Lorne F. Erdile, Bruno Guy
-
Publication number: 20040067237Abstract: The present invention relates to vaccine composition(s) comprising at least two PspAs from strains selected from at least one family, the family being defined by PspAs from strains belonging to the family having greater than or equal to 50% homology in aligned sequences of a C-terminal region of an alpha helical region of PspA. Additionally, the families are further comprised of clades, wherein PspAs from strains which belong to a clade exhibit at least 75% sequence homology in aligned sequences of the C-terminal region of the alpha helix of PspA. Vaccine compositions of the present invention preferably comprise a minimum of 4 and a maximum of 6 strains representing a single clade each, and the at least two PspAs are optionally serologically or broadly cross-reactive.Type: ApplicationFiled: September 30, 2003Publication date: April 8, 2004Inventors: Robert S. Becker, David E. Briles, Susan Hollingshead
-
Patent number: 6638516Abstract: The present invention relates to vaccine composition(s) comprising at least two PspAs from strains selected from at least one family, the family being defined by PspAs from strains belonging to the family having greater than or equal to 50% homology in aligned sequences of a C-terminal region of an alpha helical region of PspA. Additionally, the families are further comprised of clades, wherein PspAs from strains which belong to a clade exhibit at least 75% sequence homology in aligned sequences of the C-terminal region of the alpha helix of PspA. Vaccine compositions of the present invention preferably comprise a minimum of 4 and a maximum of 6 strains representing a single clade each, and the at least two PspAs are optionally serologically or broadly cross-reactive.Type: GrantFiled: May 24, 1999Date of Patent: October 28, 2003Assignee: The UAB Research FoundationInventors: Robert S. Becker, David E. Briles, Susan Hollingshead
-
Patent number: 6538118Abstract: Heterologous lipidated proteins formed recombinantly are disclosed and claimed. The expression system can be E. coli. The heterologous lipidated protein has a leader sequence which does not naturally occur with the protein portion of the lipidated protein. The lipidated protein can have the Borrelia OspA leader sequence. The protein portion can be OspC, PspA, UreA, Ure B, or a fragment thereof. Methods and compositions for forming and employing the proteins are also disclosed and claimed.Type: GrantFiled: April 28, 1998Date of Patent: March 25, 2003Assignee: Connaught Laboratories, Inc.Inventors: Robert C. Huebner, Lorne F. Erdile, Donald J. Warakomski, Jr., Robert S. Becker, Maryann B. Gray, Derek J. Pyle
-
Publication number: 20020131983Abstract: Immunological compositions and methods for making and using them. The compositions contain at least one antigen and at least one lipoprotein and optionally an adjuvant. The lipoprotein can itself be antigenic or immunogenic. The antigen can be influenza HA and the lipoprotein a recombinantly expressed product having an OspA leader for lipidation and PspA for the protein portion. The antigen can be OspC and the lipoprotein OspA. The components of the composition are co-administered. A potentiated immunological response is obtained by the compositions and methods.Type: ApplicationFiled: March 12, 2002Publication date: September 19, 2002Inventors: Robert S. Becker, Robert C. Huebner, Maryann Gray, Karen S. Biscardi, Lorne F. Erdile, Bruno Guy
-
Patent number: 6379675Abstract: Immunological compositions and methods for making and using them. The compositions contain at least one antigen and at least one lipoprotein and optionally an adjuvant. The lipoprotein can itself be antigenic or immunogenic. The antigen can be influenza HA and the lipoprotein a recombinantly expressed product having an OspA leader for lipidation and PspA for the protein portion. The antigen can be OspC and the lipoprotein OspA. The components of the composition are co-administered. A potentiated immunological response is obtained by the compositions and methods.Type: GrantFiled: January 19, 1996Date of Patent: April 30, 2002Assignee: Connaught Laboratories, Inc.Inventors: Robert S. Becker, Robert C. Huebner, Maryann Gray, Karen S. Biscardi, Lorne F. Erdile, Bruno Guy
-
Patent number: 6354222Abstract: A projectile and method for the destruction of normally explosive targets and includes a projectile shell body containing a pyrogenically activated intermetallic reactive payload in the forward section of the shell and an amount of tracer material aft of the payload in the shell body for igniting the intermediate reactive payload. The tracer material is ignited by the shell propellant upon launch.Type: GrantFiled: April 5, 2000Date of Patent: March 12, 2002Assignee: Raytheon CompanyInventors: Robert S. Becker, Kelly D. McHenry, Frederick J. Wagener